BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $117,157,000 | +145.3% | 775,004 | +136.5% | 2.53% | +101.8% |
| Q2 2022 | $47,754,000 | +8694.5% | 327,735 | +8279.8% | 1.25% | +13822.2% |
| Q3 2021 | $543,000 | -91.4% | 3,911 | -95.8% | 0.01% | -92.9% |
| Q1 2021 | $6,333,000 | +1683.9% | 92,658 | +2139.7% | 0.13% | +1170.0% |
| Q4 2020 | $355,000 | +23.7% | 4,137 | -6.3% | 0.01% | -16.7% |
| Q3 2020 | $287,000 | -55.6% | 4,413 | -76.8% | 0.01% | -79.3% |
| Q1 2020 | $647,000 | -66.8% | 19,004 | -46.9% | 0.06% | -33.3% |
| Q4 2019 | $1,950,000 | +220.2% | 35,814 | +145.3% | 0.09% | +314.3% |
| Q3 2019 | $609,000 | -50.5% | 14,598 | -48.0% | 0.02% | -40.0% |
| Q2 2019 | $1,230,000 | – | 28,094 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |